Javier F Magrina1, Paul M Magtibay. 1. Department of Medical and Surgical Gynecology, Mayo Clinic in Arizona, Phoenix, AZ 85054, USA. jmagrina@mayo.edu
Abstract
BACKGROUND: The objective of this research was to evaluate the feasibility of robotic nerve-sparing radical parametrectomy for cervical cancer after simple hysterectomy. METHODS: A 41 year-old patient was diagnosed with invasive cervical adenocarcinoma after simple hysterectomy. Hysterectomy margins were negative. A robotic nerve-sparing radical parametrectomy was offered and performed 5 weeks later. RESULTS: Total operating time was 330 min, blood loss was 145 ml and length of hospitalization 2 days. Pathology revealed no residual tumour. Normal bladder function resumed on postoperative day 9. At a follow-up of 16 months, the patient remains with no evidence of disease and with normal bladder and bowel function. CONCLUSIONS: Robotic nerve-sparing radical parametrectomy is safe and feasible and can be offered to patients with indications for radical parametrectomy.
BACKGROUND: The objective of this research was to evaluate the feasibility of robotic nerve-sparing radical parametrectomy for cervical cancer after simple hysterectomy. METHODS: A 41 year-old patient was diagnosed with invasive cervical adenocarcinoma after simple hysterectomy. Hysterectomy margins were negative. A robotic nerve-sparing radical parametrectomy was offered and performed 5 weeks later. RESULTS: Total operating time was 330 min, blood loss was 145 ml and length of hospitalization 2 days. Pathology revealed no residual tumour. Normal bladder function resumed on postoperative day 9. At a follow-up of 16 months, the patient remains with no evidence of disease and with normal bladder and bowel function. CONCLUSIONS: Robotic nerve-sparing radical parametrectomy is safe and feasible and can be offered to patients with indications for radical parametrectomy.